Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
PharmaSphere Consulting ApS
APS
Active
Advertising protection
CVR 36696222
Linde Alle 25, 2750
Ballerup
Engineering activities and related technical consultancy
·
NACE 7112
Est. 2015 · 11 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Engineering activities and related technical consultancy
/
PharmaSphere Consulting ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
4M
3M
2M
1M
0M
2021: 0M
0M
2021
2022: 1M
1M
2022
2023: 2M (+100% vs 2022)
2M
+100%
2023
2024: 3M (+50% vs 2023)
3M
+50%
2024
2025: 2M (-33% vs 2024)
2M
-33%
2025
EBITDA
DKK millions
1M
1M
1M
0M
0M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 1M
1M
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
2.480
2.630
1.680
916
138
Staff expenses
-2.068
-1.742
-1.267
-571
-21
EBITDA
412
888
413
345
116
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
412
888
413
345
116
Net financials
1
-4
-3
-4
-4
Profit before tax
413
883
410
342
112
Tax
91
195
91
75
25
Net profit
322
688
320
266
88
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
881
1.378
1.013
663
204
Equity
467
745
386
317
138
Long-term debt
0
0
0
0
0
Short-term debt
415
633
626
346
67
Total debt
415
633
626
346
67
Financial ratios
5-year trend
EBITDA margin (of gross profit)
16,6 %
This company
2021
2025
Equity ratio
52,9 %
This company
38,2 %
Market median
This company
Market median
38% above market
2021
2025
Return on equity
68,9 %
This company
18,4 %
Market median
This company
Market median
274% above market
2021
2025
Net profit margin (of gross profit)
13,0 %
This company
2021
2025
Asset turnover (of gross profit)
2,81×
This company
2021
2025
Debt / equity
0,89×
This company
0,62×
Market median
This company
Market median
44% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on PharmaSphere Consulting ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
